Late relapse versus hepatitis C virus reinfection in patients with sustained virologic response after sofosbuvir-based therapies
Late relapse versus hepatitis C virus reinfection in patients with sustained virologic response after sofosbuvir-based therapies. Clin Infect Dis. 2017;64(1):44-52. .